# Comparative study on the effects of glutamic acid and glutamine in promoting intestinal development in chicks through energy metabolism

**Authors:** Peiyu Huang, Yaoming Cui, Wenjing Liang, Li Zhang, Junquan Tian, Liping Gan, Linna Guo, Weiyu Chen, Guohao Yang, Junjun Guan

PMC · DOI: 10.5713/ab.25.0445 · Animal Bioscience · 2025-09-30

## TL;DR

This study compares how glutamic acid and glutamine affect intestinal development in chicks, finding that glutamine performs better in promoting growth and repair.

## Contribution

The study demonstrates that glutamine supplementation improves intestinal development and energy metabolism more effectively than glutamic acid in LPS-challenged chicks.

## Key findings

- Glutamine (0.20%) outperformed glutamic acid (0.05%) in enhancing body weight and ileum parameters.
- Glutamine supplementation improved epithelial proliferation and energy metabolism in intestinal organoids.
- Both amino acids upregulated genes related to intestinal development and repair.

## Abstract

This study evaluated the effects of glutamic acid (Glu) and glutamine (Gln) on the intestinal development of layer chicks with lipopolysaccharide (LPS)-induced damage.

A total of 240 healthy 0-d-old Hy-Line Brown chicks were randomly assigned to 4 treatments, each with 6 replicates. At 8 and 11 d of age, all birds (except for the control group) received two administrations of LPS. The LPS-challenged birds were divided into three dietary treatment groups: a basal diet (without additives), a 0.05% Glu-supplemented diet, and a 0.20% Gln-supplemented diet.

The LPS challenge induced intestinal injury and suppressed intestinal development in layer chicks, as evidenced by reduced growth performance, poor intestinal parameters, and morphology (p<0.05). Compared to the LPS group, dietary supplementation with 0.05% Glu and 0.20% Gln enhanced average daily gain (ADG), average daily feed intake, body weight (BW), and intestinal development parameters (including length, weight, villus height, and villus height/crypt depth) of duodenum, jejunum and ileum (p<0.05). These results could be attributed to upregulated mRNA expression levels of Mucin-2, E-cadherin, Dclk-1, Vil-1, Lysozyme, ChgA, Lgr-5, Bmi-1, ATP5F1AZ, and β-catenin (p<0.05). Furthermore, dietary supplementation with 0.20% Gln outperformed 0.05% Glu in enhancing BW, ADG, and ileum parameters (weight, length, epithelial cell count, and energy metabolism) (p<0.05). Additionally, intestinal organoids supplemented with 10 μM Gln had higher mean area, E-cadherin gene expression, and ATP content compared with those treated with 5 μM Glu in vitro (p<0.05).

Dietary supplementation with 0.05% Glu and 0.20% Gln could improve growth performance, intestinal development, and repair intestinal damage in layer chicks through enhanced epithelial proliferation and differentiation. Moreover, 0.20% Gln performed better than 0.05% Glu, which may be attributed to superior energy metabolism.

## Linked entities

- **Genes:** MUC2 (mucin 2, oligomeric mucus/gel-forming) [NCBI Gene 423101], shg (shotgun) [NCBI Gene 37386], DCLK1 (doublecortin like kinase 1) [NCBI Gene 9201], VIL1 (villin 1) [NCBI Gene 7429], lysozyme (lysozyme 1-like) [NCBI Gene 101893594], CHGA (chromogranin A) [NCBI Gene 1113], LGR5 (leucine rich repeat containing G protein-coupled receptor 5) [NCBI Gene 8549], BMI1 (BMI1 proto-oncogene, polycomb ring finger) [NCBI Gene 648], ATP5F1AZ (ATP synthase F1 subunit alpha Z chromosome) [NCBI Gene 374159], ctnnb1.S (catenin beta 1 S homeolog) [NCBI Gene 380441]
- **Chemicals:** glutamic acid (PubChem CID 611), glutamine (PubChem CID 738)

## Full-text entities

- **Genes:** CDH1 (cadherin 1) [NCBI Gene 999] {aka Arc-1, BCDS1, CD324, CDHE, ECAD, LCAM}, BMI1 (BMI1 proto-oncogene, polycomb ring finger) [NCBI Gene 648] {aka FLVI2/BMI1, PCGF4, RNF51, flvi-2/bmi-1}, VIL1 (villin 1) [NCBI Gene 7429] {aka D2S1471, VIL}, LYZ (lysozyme) [NCBI Gene 4069] {aka AMYLD5, LYZF1, LZM}, DCLK1 (doublecortin like kinase 1) [NCBI Gene 9201] {aka CL1, CLICK1, DCAMKL1, DCDC3A, DCLK}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, MUC2 (mucin 2, oligomeric mucus/gel-forming) [NCBI Gene 4583] {aka MLP, MUC-2, SMUC}, CHGA (chromogranin A) [NCBI Gene 1113] {aka CGA, PHE5, PHES}, LGR5 (leucine rich repeat containing G protein-coupled receptor 5) [NCBI Gene 8549] {aka FEX, GPR49, GPR67, GRP49, HG38}
- **Diseases:** intestinal damage (MESH:D007410)
- **Chemicals:** Gln (MESH:D005973), LPS (MESH:D008070), Glu (MESH:D018698), ATP (MESH:D000255)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12877385/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12877385/full.md

## References

45 references — full list in the complete paper: https://tomesphere.com/paper/PMC12877385/full.md

---
Source: https://tomesphere.com/paper/PMC12877385